Hjem › Gliom › Ohio › Columbus
Gliom kliniske forsøg i Columbus, OH
15 studier for Gliom søger deltagere på steder i og omkring Columbus (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
RekruttererFase 1/2
- Nationwide Children's Hospital, Columbus
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RekruttererFase 2
- Ohio State University, Columbus
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
RekruttererFase 2
- Nationwide Children's Hospital, Columbus
Targeted Pediatric High-Grade Glioma Therapy
RekruttererObservationsstudie
- Nationwide Children's Hospital, Columbus
Study of Olutasidenib and Temozolomide in HGG
RekruttererFase 2
- Nationwide Children's Hospital, Columbus
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RekruttererFase 2
- Nationwide Children's Hospital, Columbus
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekruttererFase 2
- The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
Rekrutterer
- Ohio State University Medical Center, Columbus
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
RekruttererFase 1/2
- Nationwide Children's Hospital, Columbus
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RekruttererTidlig fase 1Frivillige med god helbredstilstand velkomne
- Nationwide Children's Hospital, Columbus
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RekruttererFase 2
- Nationwide Children's Hospital, Columbus
Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
RekruttererFase 1
- Ohio State University Comprehensive Cancer Center, Columbus
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RekruttererFase 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
RekruttererTidlig fase 1
- Nationwide Children's Hospital, Columbus
Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells
RekruttererFase 1
- Nationwide Children's Hospital, Columbus
Gliom forsøg i andre byer
- New York City, NY25 studier
- Houston, TX23 studier
- Boston, MA20 studier
- Washington, DC19 studier
- Philadelphia, PA16 studier
- Miami, FL15 studier
- San Francisco, CA14 studier
- Chicago, IL13 studier
- Durham, NC12 studier
- Seattle, WA11 studier
- Los Angeles, CA10 studier
- St. Louis, MO10 studier
Andre studier i Columbus
- Ikke-småcellet lungecancer56 studier
- Brystkræft39 studier
- Ægstockræft39 studier
- Kræft (alle typer)38 studier
- Lungecancer37 studier
- Akut myeloid leukæmi35 studier
- Kronisk lymfatisk leukæmi28 studier
- Metastatisk cancer27 studier
- Livmoderslimhindekræft25 studier
- Colorektal kræft24 studier
- Prostatakræft24 studier
- Multipelt myelom24 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.